IOCUCOAT SODIUM HYALURANATE 3% With CHONDRIOTIN SULFATE 4% PFS 1ML SOLUTION

Price 750.0 INR/ Piece

Get a Price/Quote

MOQ : 50 Pieces

IOCUCOAT SODIUM HYALURANATE 3% With CHONDRIOTIN SULFATE 4% PFS 1ML SOLUTION Trade Information

Minimum Order Quantity
50 Pieces

Delivery Time
2 Days

About IOCUCOAT SODIUM HYALURANATE 3% With CHONDRIOTIN SULFATE 4% PFS 1ML SOLUTION

SODIUM HYALURANATE WITH CHONDRIOTIN SULFAPHATE PFSiOCUCOAT - Ophthalmic Viscosurgical Device has an intermediate cohesive/dispersive index (CDI). It is a strerile, non-pyrogenic, viscoelastic solution of a highly purified non-inflammatory medium molecular weight fraction of sodium hyaluronate and sodium chondroitin sulphate. iOcuCoat maintains a deep chamber during anterior segment surgeries, enhances visualization during the surgical procedure, and protects the corneal endhothelium and other ocular tissues. The viscoelasticity of the solution maintains the normal position of the vitereous face, thus preventing formation of a postoperative flat chamber. It is designed to create and maintain space, to protech the corenal endothelium and other introcular tissues and to manipulate tissues during surgery.

iOcuCoat (Sodium Hyaluronate 3% / Chondroitin Sulfate 4%) is a sterile, viscoelastic, pre-filled syringe (PFS) used as an ophthalmic viscosurgical device (OVD) in eye surgeries, such as cataract extraction, intraocular lens (IOL) implantation, and glaucoma procedures. It protects the corneal endothelium, maintains deep chamber depth, and reduces surgical trauma.

Key Details and Usage:

Composition: A blend of 3% Sodium Hyaluronate (provides viscosity) and 4% Sodium Chondroitin Sulfate (provides dispersive tissue protection).
Function: Acts as a space maintainer and lubricant, reducing post-operative inflammation and protecting delicate ocular tissues.
Packaging: Supplied in a sterile 1 ml glass pre-filled syringe (PFS), usually with a 27G angular cannula for precision.
Physical Properties: Features a pH of 6.5-7.6 and a high molecular weight, designed to maintain the vitreous face position during anterior segment surgeries.
Common Use: Primarily used in cataract surgery (phacoemulsification) to ensure a stable chamber.